Novartis | NOVARTIND | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
917
1,575
858
286
400
Cash flow Operating Act...
Cash flow Operating Activities
-3801,610-1,943-231-692
Investments in PPE
Investments in PPE
-28-8162-10-0.9
Cash flow Investing Act...
Net cash used for Investment Activities
4,2086872,742559952
Dividend Paid
Dividend Paid
319338247298247
Cash flow Financing Act...
Net cash provided by Financing Activities
-3,318-2,677-298-414-368
Cash at beginning of period
Cash at beginning of period
246756376878791
Cash at end of period
Cash at end of period
756376878791683
Free Cash Flow
Free Cash Flow
-408
1,602
-1,781
-241
-693